SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant market attention following landmark regulatory approval in Japan and a wave of analyst price target upgrades, fueling a strong bullish sentiment among investors. The community is actively discussing the stock's robust clinical pipeline, its fortress balance sheet with a multi-year cash runway, and the potential for a major valuation re-rate as upcoming U.S. clinical trial milestones approach.

On November 2021, 4chan created a female alternative to Wojak/PePe called “GleGle.”

glegle

GLEGLE is trending as retail investors rally behind the low-market-cap meme coin, focusing on aggressive community-led buying efforts to drive valuation higher. While many participants view it as a high-risk speculative play, others remain heavily engaged in social media campaigns to maintain momentum and reach higher market cap milestones.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is capturing significant community attention as a high-volatility energy play tied to escalating geopolitical tensions in the Middle East and concerns over natural gas supplies. Investors are actively discussing the stock's potential for a major short squeeze, frequently citing its low float and high cost-to-borrow as bullish indicators alongside ongoing volatility in energy markets.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently a focal point for investors as the community debates the impact of recent convertible note offerings, institutional buying patterns, and high short interest against a backdrop of potential acquisition rumors. Discussions are heavily focused on the clinical progress of their gene-editing pipeline, with sentiment split between long-term confidence in their breakthrough technology and frustration over the stock's stagnant price action and management's capital allocation strategies.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to a massive earnings beat and the announcement of a strategic acquisition of SkyWater Technology, which has triggered a significant short squeeze. While bulls celebrate the company's revenue growth and aggressive expansion in the quantum sector, skeptics are actively highlighting risks related to potential share dilution and concerns over the company's long-term path to profitability.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently capturing community attention as investors debate whether current price levels represent a significant accumulation opportunity or a signal of further downside. Market participants are actively discussing price stability, the potential for institutional integration, and the project's long-term utility versus its short-term volatility.

The Shrimp Army

SHRIMPS is trending as part of a wider wave of marine-themed meme coins that investors are actively rotating through. While the community is hyped about potential price breakouts and the ability to eliminate zeros, many participants are cautioning others about the extreme volatility and high risk of quick pullbacks common in this sector.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly (LLY) is trending as the market processes a competitive trial readout comparing its oral drug orforglipron to Novo Nordisk's oral semaglutide, with investors debating the trade-off between higher efficacy and greater side-effect-related discontinuation rates. Concurrently, sentiment is pressured by an HSBC downgrade citing valuation concerns, while community discussion remains focused on the long-term impact of regulatory scrutiny regarding compounded GLP-1 alternatives and the stock's positioning ahead of major FDA milestones.

Sui is an innovative layer-1 blockchain platform crafted to meet the demands of global adoption, providing a secure, robust, and scalable development environment. Rooted in a unique object-centric data model and fortified by the trusted Move programming language, Sui is engineered to tackle the inefficiencies found in current blockchain frameworks.  In addition to its solid technical underpinnings, Sui places a strong emphasis on user experience, aiming to remove common barriers encountered in blockchain interactions. Through groundbreaking features such as zkLogin, sponsored transactions, and programmable transaction blocks, Sui sets a new standard for user accessibility and friendliness within Web3 applications.  Unique elements of Sui Sui’s innovative architecture ensures swift transactions with stable fees and high throughput through horizontal scaling. Its object-oriented design offers deep composability for developers, enabling tailored object types with network-wide compatibility. This revolutionizes asset and protocol collaboration, fostering product innovation.  The platform's object-oriented approach dramatically improves transaction processing, enabling parallel execution and faster completion times. Additionally, unique consensus requirements expedite transaction finalization while maintaining stability. Sui prioritizes overcoming Web3 adoption barriers, offering native tools like zkLogin and sponsored transactions for wallet onboarding and fee management.  Move integration into Sui's data model combines innovation with security, mitigating common exploits found in smart contract languages. This empowers developers and users with a secure and intuitive platform, accelerating the evolution of Web3 applications.  About the Sui token The SUI token serves four primary functions within the Sui ecosystem: Proof-of-stake participation - Sui implements a delegated proof-of-stake mechanism, rewarding honest behavior by validators and SUI token holders who stake with them. Gas fee payments - SUI tokens cover gas fees for executing transactions and storing data onchain. Application utility - SUI is a versatile asset, integral to various applications within Sui’s ecosystem, including decentralized exchanges, lending platforms, gaming, and more. Governance - The SUI token empowers holders to participate in on-chain voting on significant matters like protocol upgrades and platform changes, shaping the future of Sui.  Additionally, the Sui storage fund ensures fair compensation for validators by distributing stake rewards over time and covering storage costs for previously stored on-chain data. This tokenomic strategy promotes indefinite data storage while maintaining fair compensation for validators, fostering long-term sustainability.

SUI is experiencing heightened market activity driven by bullish sentiment and anticipation of upcoming ecosystem expansion, including ETF launches and increased network utility. The community is actively discussing accumulation strategies and potential price appreciation, drawing comparisons between SUI and other established layer-one networks.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest news of CPU price hikes alongside aggressive AI demand, fueling a strong technical breakout that has shifted sentiment from recent consolidation to bullish momentum. While some community members remain cautious about geopolitical risks and potential profit-taking, the broader discussion highlights strong institutional interest and long-term confidence in the company's competitive position in the AI hardware space.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$STEK big volume but moving up today! Any news?

StockTwits For Android 

Stemtech Corp

 big volume but moving up today! Any news?